Active catalysts for stereoselective ring-opening reactions
AssigneeRhodia Pharma Solutions Inc.
InventorsJay F. Larrow, Karl Hemberger, Hocine Kabir, Philippe Morel
Life of this patent
Estimating the term…
Loading patent…
AssigneeRhodia Pharma Solutions Inc.
InventorsJay F. Larrow, Karl Hemberger, Hocine Kabir, Philippe Morel
Estimating the term…
A method for making a chiral transition metal-ligand catalyst complex that is active in catalyzing stereoselective ring opening reactions includes contacting an asymmetric tetradentate ligand, in an excess of a Brønsted acid, with a salt of a first row transition metal, wherein the acidity of the conjugate acid of the salt is the same as or less than the acidity of the Brønsted acid, under conditions effective to allow formation of the active chiral transition metal-ligand catalyst complex, and forming a solution of the complex in a water-miscible, protic solvent from which the active complex can be precipitated by the addition of water and adding water to the solution to precipitate at least a portion of the complex.
A method for making a chiral catalyst complex, comprising:
A method of making chiral catalyst complex, comprising:
A method for making a chiral catalyst complex in particulate solid form, comprising:
A catalyst active in catalyzing stereoselective ring opening reactions, comprising a chiral catalyst complex of Co(III) or Cr(III) with an asymmetric tetradentate ligand and a counterion or nucleophile selected from carboxylate, hydroxide, alkoxide, thiolate, sulfonate, sulfonamide, isocyanate, isothiocyanate, and halide, wherein the complex is in crystalline solid form, wherein at least one molecule of the chiral catalyst complex further comprises a molecule of methanol.
The method of claim 29, wherein R40 and R42 are fused to, together with the carbon atoms to which they are attached, form a 1,2-cyclohexylene group.
Dependencies are inferred from the claim text.